{"id":"W3206925815","doi":"10.1016/j.cjca.2021.07.030","title":"ANTITHROMBOTIC THERAPIES IN CANADIAN ATRIAL FIBRILLATION PATIENTS WITH CONCOMITANT CORONARY ARTERY DISEASE: INSIGHTS FROM THE CONNECT AF+PCI-I AND -II PROGRAMS","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Conventional PCI; Internal medicine; Atrial fibrillation; Rivaroxaban; Cardiology; Percutaneous coronary intervention; Antithrombotic; Coronary artery disease; Acute coronary syndrome; Apixaban; Ticagrelor; Edoxaban; Dabigatran; TIMI; Prasugrel; Clopidogrel; Warfarin; Myocardial infarction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008728166,0.0003068975,0.0003788829,0.001054154,0.001228465,0.001253728,0.0007936871,0.0005988771,0.002279275],"category_scores_gemma":[0.00530776,0.0001765149,0.0006889455,0.003840093,0.000321603,0.0003976543,0.001027737,0.001248971,0.0001732327],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01631557,"about_ca_system_score_gemma":0.04616609,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9414993,"about_ca_topic_score_gemma":0.98101,"domain_scores_codex":[0.9986463,0.0001362865,0.0000661665,0.00009051075,0.0006268561,0.0004337937],"domain_scores_gemma":[0.9968971,0.0003753731,0.0007499722,0.0000545689,0.0009852438,0.0009377094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008106841,0.0007071242,0.8654121,0.0003493219,0.0003428939,0.0001248943,0.0007089683,0.0004553358,0.0001324405,0.001604612,0.03602611,0.09332557],"study_design_scores_gemma":[0.000182978,0.00008391559,0.9911504,0.0002622088,0.000230969,0.000067248,0.0007504053,0.0003788854,0.00004073157,0.0002036615,0.006627421,0.00002126574],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.87968,0.01351995,0.000256481,0.02684417,0.0002400604,0.000340877,0.02815084,0.00003821379,0.05092948],"genre_scores_gemma":[0.9694681,0.01193327,0.001105011,0.003795937,0.000319795,0.0001927433,0.01118839,0.00001438862,0.001982321],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05850071,"threshold_uncertainty_score":0.1183783,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02382516342244815,"score_gpt":0.2447284567679973,"score_spread":0.2209032933455491,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}